R
Robert A. Everley
Researcher at Pfizer
Publications - 2
Citations - 64
Robert A. Everley is an academic researcher from Pfizer. The author has contributed to research in topics: TEC & Kinase. The author has an hindex of 1, co-authored 2 publications receiving 22 citations.
Papers
More filters
Journal ArticleDOI
PF-06651600, a Dual JAK3/TEC Family Kinase Inhibitor.
Hua Xu,Michael I. Jesson,Uthpala Seneviratne,Tsung H. Lin,M Nusrat Sharif,Liang Xue,Chuong Nguyen,Robert A. Everley,John I. Trujillo,Douglas S. Johnson,Gary R. Point,Atli Thorarensen,Iain Kilty,Jean-Baptiste Telliez +13 more
TL;DR: Preclinical data demonstrate that inhibition of the cytolytic function of CD8+ T cells and NK cells by PF-06651600 is driven by the inhibition of TEC kinases.
Journal ArticleDOI
A Comparison of Two Stability Proteomics Methods for Drug Target Identification in OnePot 2D Format.
TL;DR: In this article, the authors compared SPROX and TPP to identify protein targets of a pan-kinase inhibitor staurosporine with K562 lysate, in curve-fitting and OnePot 2D formats.